223 related articles for article (PubMed ID: 10851284)
1. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
Obermayer-Straub P; Strassburg CP; Manns MP
Can J Gastroenterol; 2000 May; 14(5):429-39. PubMed ID: 10851284
[TBL] [Abstract][Full Text] [Related]
2. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.
Mizutani T; Shinoda M; Tanaka Y; Kuno T; Hattori A; Usui T; Kuno N; Osaka T
Drug Metab Rev; 2005; 37(1):235-52. PubMed ID: 15747502
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.
Miyakawa H; Kitazawa E; Kikuchi K; Fujikawa H; Kawaguchi N; Abe K; Matsushita M; Matsushima H; Igarashi T; Hankins RW; Kako M
Autoimmunity; 2000; 33(1):23-32. PubMed ID: 11204250
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens.
Obermayer-Straub P; Manns MP
Mol Biol Rep; 1996; 23(3-4):235-42. PubMed ID: 9112234
[TBL] [Abstract][Full Text] [Related]
6. Cytochromes P450 and UDP-glucuronosyl-transferases as hepatocellular autoantigens.
Obermayer-Straub P; Manns MP
Baillieres Clin Gastroenterol; 1996 Sep; 10(3):501-32. PubMed ID: 8905121
[TBL] [Abstract][Full Text] [Related]
7. Viral induction of autoimmunity: mechanisms and examples in hepatology.
Manns MP; Obermayer-Straub P
J Viral Hepat; 1997; 4 Suppl 2():42-7. PubMed ID: 9429209
[TBL] [Abstract][Full Text] [Related]
8. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
[TBL] [Abstract][Full Text] [Related]
9. High levels of autoantibodies against drug-metabolizing enzymes in SLA/LP-positive AIH-1 sera.
Shinoda M; Tanaka Y; Kuno T; Matsufuji T; Matsufuji S; Murakami Y; Mizutani T
Autoimmunity; 2004; 37(6-7):473-80. PubMed ID: 15621574
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
Dalekos GN; Makri E; Loges S; Obermayer-Straub P; Zachou K; Tsikrikas T; Schmidt E; Papadamou G; Manns MP
Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):35-42. PubMed ID: 11782573
[TBL] [Abstract][Full Text] [Related]
11. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
Klein R; Zanger UM; Berg T; Hopf U; Berg PA
Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies and defined target autoantigens in autoimmune hepatitis: an overview.
Dalekos GN; Zachou K; Liaskos C; Gatselis N
Eur J Intern Med; 2002 Aug; 13(5):293-303. PubMed ID: 12144908
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Zachou K; Rigopoulou E; Dalekos GN
J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
[TBL] [Abstract][Full Text] [Related]
14. Cytochromes P450 as targets to autoantibodies in immune mediated diseases.
Boitier E; Beaune P
Mol Aspects Med; 1999; 20(1-2):84-137. PubMed ID: 10575654
[No Abstract] [Full Text] [Related]
15. Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1.
Clemente MG; Meloni A; Obermayer-Straub P; Frau F; Manns MP; De Virgiliis S
Gastroenterology; 1998 Feb; 114(2):324-8. PubMed ID: 9453493
[TBL] [Abstract][Full Text] [Related]
16. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
[TBL] [Abstract][Full Text] [Related]
17. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F
J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122
[TBL] [Abstract][Full Text] [Related]
18. Characterization of autoantibodies against uridine-diphosphate glucuronosyltransferase in patients with inflammatory liver diseases.
Bachrich T; Thalhammer T; Jäger W; Haslmayer P; Alihodzic B; Bakos S; Hitchman E; Senderowicz AM; Penner E
Hepatology; 2001 May; 33(5):1053-9. PubMed ID: 11343231
[TBL] [Abstract][Full Text] [Related]
19. Hepatotropic viruses and autoimmunity 1997.
Manns MP
J Viral Hepat; 1997; 4 Suppl 1():7-10. PubMed ID: 9097272
[TBL] [Abstract][Full Text] [Related]
20. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.
Bourdi M; Chen W; Peter RM; Martin JL; Buters JT; Nelson SD; Pohl LR
Chem Res Toxicol; 1996; 9(7):1159-66. PubMed ID: 8902272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
